Euro Surveill. Carbapenemase-producing Enterobacteriaceae in Europe: a survey among national experts from 39 countries, February 2013

[Giuseppe]

[Source: Eurosurveillance, full page: (LINK). Abstract, edited.]


Eurosurveillance, Volume 18, Issue 28, 11 July 2013

Rapid communications

Carbapenemase-producing Enterobacteriaceae in Europe: a survey among national experts from 39 countries, February 2013


C Glasner<SUP>1</SUP>, B Albiger<SUP>2</SUP>, G Buist<SUP>1</SUP>, A Tambić Andra?ević<SUP>3</SUP>, R Canton<SUP>4</SUP><SUP>,5</SUP>, Y Carmeli<SUP>6</SUP>, A W Friedrich<SUP>1</SUP>, C G Giske<SUP>7</SUP><SUP>,8</SUP>, Y Glupczynski<SUP>9</SUP>, M Gniadkowski<SUP>10</SUP>, D M Livermore<SUP>11</SUP><SUP>,12</SUP>, P Nordmann<SUP>13</SUP><SUP>,14</SUP>, L Poirel<SUP>13</SUP><SUP>,14</SUP>, G M Rossolini<SUP>15</SUP>, H Seifert<SUP>16</SUP>, A Vatopoulos<SUP>17</SUP>, T Walsh<SUP>12</SUP>, N Woodford<SUP>18</SUP>, T Donker<SUP>1</SUP>, D L Monnet<SUP>2</SUP>, H Grundmann <SUP>1</SUP>, the European Survey on Carbapenemase-Producing Enterobacteriaceae (EuSCAPE) working group<SUP>19</SUP>

1. Department of Medical Microbiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands
2. European Centre for Disease Prevention and Control, Stockholm, Sweden
3. Department of Clinical Microbiology, University Hospital for Infectious Diseases, Zagreb, Croatia
4. Servicio de Microbiolog?a, Hospital Universitario Ram?n y Cajal and Instituto Ram?n y Cajal de Investigaci?n Sanitaria (IRYCIS), Madrid, Spain
5. Unidad de Resistencia a Antibi?ticos y Virulencia Bacteriana asociada al Consejo Superior de Investigaciones Cient?ficas (CSIC), Madrid, Spain
6. Division of Epidemiology, Tel-Aviv Sourasky Medical Centre, Tel-Aviv, Israel
7. Clinical Microbiology, MTC - Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden
8. Swedish Institute for Communicable Disease Control, Solna, Sweden
9. National Reference Laboratory for Antibiotic Resistance Monitoring in Gram-negative Bacteria, CHU Mont Godinne, Universit? Catholique de Louvain, Yvoir, Belgium
10. Department of Molecular Microbiology, National Medicines Institute, Warsaw, Poland
11. Norwich Medical School, University of East Anglia, Norwich, United Kingdom
12. Section of Medical Microbiology IIB, School of Medical Sciences, Cardiff University, Heath Park Hospital, Cardiff, United Kingdom
13. INSERM U914 ?Emerging Resistance to Antibiotics?, Associated National Reference Center for Antibiotic Resistance, Facult? de M?decine et Universit? Paris-Sud, K. Bic?tre, France
14. Medical and Molecular Microbiology Unit, Department of Medicine, Faculty of Science, University of Fribourg, Switzerland
15. Dipartimento di Biotecnologie Mediche, Universit? di Siena, Siena; Dipartimento di Medicina Sperimentale e Clinica, Universit? di Firenze; SOD Microbiologia e Virologia, Azienda Ospedaliera-Universitaria Careggi, Firenze, Italy
16. Institute for Medical Microbiology, Immunology and Hygiene, Cologne University, Cologne, Germany
17. Department of Microbiology, National School of Public Health, Athens, Greece
18. Antimicrobial Resistance and Healthcare Associated Infections Reference Unit, Public Health England, London, United Kingdom
19. The EuSCAPE working group participants are listed at the end of the article

________

Citation style for this article: Glasner C, Albiger B, Buist G, Tambić Andra?ević A, Canton R, Carmeli Y, Friedrich AW, Giske CG, Glupczynski Y, Gniadkowski M, Livermore DM, Nordmann P, Poirel L, Rossolini GM, Seifert H, Vatopoulos A, Walsh T, Woodford N, Donker T, Monnet DL, Grundmann H, the European Survey on Carbapenemase-Producing Enterobacteriaceae (EuSCAPE) working group. Carbapenemase-producing Enterobacteriaceae in Europe: a survey among national experts from 39 countries, February 2013 . Euro Surveill. 2013;18(28)ii=20525. Available online: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20525
Date of submission: 21 June 2013
________

The spread of carbapenemase-producing Enterobacteriaceae (CPE) is a threat to healthcare delivery, although its extent differs substantially from country to country. In February 2013, national experts from 39 European countries were invited to self-assess the current epidemiological situation of CPE in their country. Information about national management of CPE was also reported. The results highlight the urgent need for a coordinated European effort on early diagnosis, active surveillance, and guidance on infection control measures.


-
-------